Christina T. Loguidice

Articles

Looking for Zebras in Metastatic Colorectal Cancer

January 4th 2019

During a recent OncLive Peer Exchange®, a panel of CRC experts discussed the heterogeneity of metastatic CRC and the need to identify patient subsets within this disease to enable a precision medicine approach.

Advanced Gastroesophageal Cancer: What Have We Learned, and What's Next

December 29th 2018

Investigators have achieved some success with immune checkpoint inhibitors and antiangiogenesis agents in patients with advanced gastroesophageal cancers, and exciting new agents targeting different tumor growth pathways are under investigation.

Current and Prospective Therapies Are Improving Outcomes in Relapsed Multiple Myeloma

November 24th 2018

During an OncLive Peer Exchange®, a panel of experts on multiple myeloma discussed new agents and combinations that are improving the care of patients with relapsed multiple myeloma and reviewed strategies for treating these patients when they develop drug resistance.

Modern Therapies Expand Options for Soft-Tissue Sarcomas

November 8th 2018

Although soft-tissue sarcoma is seldom diagnosed in adults, the development of several new therapies in recent years for patients with rare subtypes is energizing leaders in the field and underscoring the need for a multidisciplinary approach to care.

Adjuvant Therapy for Melanoma: Who, What, When?

September 28th 2018

More patients than ever before may now be good candidates for adjuvant therapy and derive long-term benefits from it, but new data and expanding treatment options have led to many new questions on how to optimize treatment for melanoma.

Experts Delve Into 4 Phenotypes of Advanced Prostate Cancer

August 20th 2018

A panel of experts during an OncLive PeerExchange® provided practical definitions for biochemical recurrent hormone-naïve nonmetastatic, metastatic hormone-naïve advancing, nonmetastatic castration-resistant, and metastatic castration-resistant prostate cancer.

Boom in Targeted Agents Propels AML Treatment Into a New Era of Personalized Care

June 12th 2018

During an OncLive Peer Exchange® a panel of AML experts discussed these newly approved agents and provided insight on how they are rapidly changing the standard of care for various AML subgroups.

Novel Agents Change the Treatment of Acute Lymphoblastic Leukemia

May 29th 2018

A panel of experts discuss the latest data on several novel agents for ALL and provided insights on how to align these treatments in challenging settings.

Sorting Through the Alphabet Soup of Evolving Treatments in CLL

May 15th 2018

Experts offer their perspectives on developments in the field of chronic lymphocytic leukemia, such as novel combinations and emerging agents.

The Hunt for Biomarkers and Better Treatments in Advanced TNBC

May 21st 2017

In an OncLive Peer Exchange® discussion, experts in breast malignancies reviewed some exciting new developments in TNBC.

Can the Breakthrough Therapy Program Transform Cancer Care?

December 23rd 2015

In the three years since the FDA launched its breakthrough therapy program, the designation has become a coveted status for emerging agents as biopharmaceutical companies scramble to make their mark in an increasing competitive environment.

Standardization Is Key to Future of "Chemotherapy Bath"

October 30th 2015

A combination of cytoreductive surgical resection and hyperthermic intraperitoneal chemotherapy-sometimes referred to as "hot chemotherapy bath"-has the potential to provide some patients with long-term survival.

New Therapeutic Target Identified for Ovarian Cancer Subtype

March 18th 2015

Inhibiting EZH2 may improve outcomes in patients with clear cell ovarian carcinoma who harbor a ARID1A mutation.

Medication Adherence Technologies: Promise or Pitfalls?

June 2nd 2010

Historically, most cancer treatments have been administered in oncology offices or hospitals, but oral medications are becoming increasingly common, and oral formulations of chemotherapy, targeted therapies, and hormonal therapies are available.

Digital Ink: Leaving a Mark on Medicine

May 19th 2010

The Ancient Indians were the fi rst to use pens around 5000 BCE. While these writing implements were primitive, typically consisting of hollowed out reeds that could hold a small amount of ink, which was generally soot in water with a plant gum binder, they were used for thousands of years and are still used today in certain parts of Pakistan.

The Invisible Killer in Your Home: Understanding Radon, Testing, and Mitigation

May 14th 2010

Radon is an invisible, odorless, and tasteless radioactive gas that is released into the air or dissolves into groundwater as uranium in rocks or soil decays.

PROTONS: A ray of hope in oncology

May 5th 2010

Radiation therapy has been used to treat cancer for more than 100 years, and was made possible by the discovery of X-rays in 1895 by German physicist Wilhelm Conrad Röntgen, which allowed tumors to be detected more easily and noninvasively.

5 CINV Web Resources for Patients

April 27th 2010

Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and most feared side effects of chemotherapy.

Personalized Medicine: What does the future hold?

April 23rd 2010

The concept of personalized medicine is not new. As doctor Ogan Gurel points out in an article published in 2007 on WTN News, personalized medicine has been practiced since ancient times in the form of surgery.

5 Benefits of Twittering

April 30th 2009

Twitter really only wants to know one thing: "What are you doing?"

NEXT PAGE
PREVIOUS PAGE